University of Oxford

Degree level: Postgraduate

Experimental and Translational Therapeutics (Taught)

Make sure you check on the university, college or conservatoire website for any updates about course changes as a result of COVID-19.

Course summary

The information provided on this page was correct at the time of publication (October/November 2022). For complete and up-to-date information about this course, please visit the relevant University of Oxford course page via www.graduate.ox.ac.uk/ucas The Department of Oncology and the Department for Continuing Education offer the part-time MSc in Experimental and Translational Therapeutics, bringing together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment. Oxford has made a major contribution to modern molecular medicine and Oxford’s senior scientists have provided significant insights to our understanding of cancer, diabetes, and cardiac, haematological and infectious diseases. There is an opportunity to harness these advances and translate them into therapeutic benefits for patients. The MSc in Experimental and Translational Therapeutics draws on the world class research and teaching in experimental therapeutics at the University of Oxford and aims to provide you with the necessary training and practical experience to enable you to understand the principles that underpin clinical research, and to translate that understanding into good clinical and research practice. The programme will appeal to health professionals from a variety of backgrounds, including:

  • qualified doctors
  • specialist registrars in clinical pharmacology or in training for other medical sub-specialities
  • clinical research fellows
  • pharmacists
  • nurses
  • graduates working in the pharmaceutical industry or in academic clinical trials.
The MSc is a part-time course consisting of six modules and a research project and dissertation. The programme is normally completed in two to three years, but up to a maximum of four years may be taken. You will be a full member of the University of Oxford and matriculated as a member of a college. The six modules are:
  • The Structure of Clinical Trials and Experimental Therapeutics
  • Drug Development, Pharmacokinetics and Imaging
  • Pharmacodynamics, Biomarkers and Personalised Therapy
  • Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance
  • How to do Research on Therapeutic Interventions: Protocol Preparation
  • Biological Therapeutics.
The class-based taught modules consist of five days of intensive face-to-face lectures and tutorials, and are followed by a period for assignment work. Attendance at modules is a requirement for study. A virtual learning environment (VLE) provides between-module support, and assignments are submitted online. The modules include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers, as well as practical work that develops your knowledge and understanding of the subject. It is recommended that you plan to spend around eight to ten hours per week in private study in addition to time spent in classes or participating in on-line learning. The dissertation is founded on a research project that builds on material studied in the taught modules. The project is normally supervised by an academic supervisor from the University of Oxford, and an employer-based mentor.


Entry requirements

For complete and up-to-date information about this course, please visit the relevant University of Oxford course page via www.graduate.ox.ac.uk/ucas


Fees and funding

Tuition fees

No fee information has been provided for this course

Additional fee information

For complete and up-to-date information about fees and funding for this course, please visit the relevant University of Oxford course page via www.graduate.ox.ac.uk/ucas.
Experimental and Translational Therapeutics at University of Oxford - UCAS